Heart allografts in murine systems: The differential activation of TH2-like effector cells in peripheral tolerance

Transplantation

Volumn 53, Issue 6, 1992, Pages 1281-1294

  Takeuchi, T ^a   Lowry, Robin P ^a   Konieczny, B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CYCLOSPORIN; CYTOKINE; FC RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 2;

ALLOIMMUNITY; ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; DELAYED HYPERSENSITIVITY; EFFECTOR CELL; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART GRAFT; HEART TRANSPLANTATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN TRANSPLANTATION;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CYCLOSPORINE; CYTOKINES; HEART TRANSPLANTATION; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MICE; POLYMERASE CHAIN REACTION; RECEPTORS, FC; SPLEEN; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, HELPER-INDUCER; TRANSPLANTATION, HOMOLOGOUS;

EID: 0026729563     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199206000-00023     Document Type: Article

References (119)

1. Cher DJ, Mosmann TR. Two types of murine helper T cell clones: II. Delayed-type hypersensitivity is mediated by Thl clones. J Immunol 1987; 138: 3688.
2. Barth RJ Jr, Mul JJ, Spiess PJ, Rosenberg SA. Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes. J Exp Med 1991; 173: 647.
3. Fong TAT, Mosmann TR. Alloreactive murine CD8+ T cell clones secrete the Thl pattern of cytokines. J Immunol 1990; 144: 1744.
4. Mosmann TR, Coffman RL. Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 143.
5. Mosmann TR, Moore KW. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 1991; 12: A49.
6. Lowry RP, Takeuchi T. Immunologic tolerance and its relationship to clinical transplantation. In: Solez K, Burdick J, eds. Transplant rejection. New York: Dekker, 1992: 83-233.
7. DeKruyff RH, Ju S-T, Hunt AJ, Mosmann TR, Umetsu DT. Induction of antigen-specific antibody responses in primed and unprimed B cells: functional heterogeneity among Thl and Th2 T cell clones. J Immunol 1989; 142: 2575.
8. Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990; 145: 3796.
9. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990; 248: 1230.
10. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones. J Exp Med 1989; 170: 2081.
11. Qian J-H, Hashimoto T, Fujiwara H, Hamaoka T. Studies on the induction of tolerance to alloantigens: I. The abrogation of potentials for delayed-type-hypersensitivity to alloantigens by portal venous inoculation with allogeneic cells. J Immunol 1985; 134: 3656.
12. Kenick S, Lisbona R, Marghesco D, Lowry RP. Prolonged cardiac allograft survival following portal venous infusion of allogeneic cells: immunologically specific entrapment of allogeneic cells within the liver. Transplant Proc 1987; 19: 3057.
13. Streilein JW, Wegmann TG. Immunologic privilege in the eye and the fetus. Immunol Today 1987; 8: 362.
14. Burkly LC, Lo D, Kanagawa O, Brinster RL, Flavell RA. T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E. Nature 1989; 342: 564.
15. Alters SE, Shizuru JA, Ackerman J, Grossman D, Seydel KB, Fathman CG. Anti-CD4 mediates clonal anergy during transplantation tolerance induction. J Exp Med 1991; 173: 491.
16. Sato S, Azuma T, Shimizu J, et al. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset: abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells. J Immunol 1988; 141: 721.
17. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin-2 pathway. J Exp Med 1991; 173: 79.
18. Hori S, Sato S, Kitagawa S, et al. Tolerance induction of allo-class II H-2 antigen-reactive L3T4 helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft. J Immunol 1989; 143: 1447.
19. Kawabe Y, Ochi A. Programmed cell death and extrathymic reduction of V-beta-8+, CD4* T cells in staphylococcus entero-toxin B-specific tolerance. Nature 1990; 349: 245.
20. Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 1990; 63: 1249.
21. Rocha B, von Boehmer H. Peripheral selection of the T cell repertoire. Science 1991; 251: 1225.
22. Jones LA, Chin LT, Longo DL, Kruisbeek AM. Peripheral clonal elimination of functional T cells. Science 1990; 250: 1726.
23. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273.
24. Newell MK, Haughn LJ, Maroun CR, Julius MH. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 1990; 347: 286.
25. Gilbert KM, Hoang KD, Weigle WO. Thl and Th2 clones differ in their response to a tolerogenic signal. J Immunol 1990; 144: 2063.
26. Davis LS, Wacholtz MC, Lipsky PE. The induction of T cell unresponsiveness by rapidly modulating CD3. J Immunol 1989; 142: 1084.
27. Williams ME, Lichtman AH, Abbas AK. Anti-CD3 antibody induces unresponsiveness to IL-2 in Thl clones but not in Th2 clones. J Immunol 1990; 144: 1208.
28. Liu Y, Janeway CA. Interferon-gamma plays a critical role in induced cell death of effector T cell: A possible third mechanism of self tolerance. J Exp Med 1990; 172: 1735.
29. Otten GR, Germain RN. Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science 1991; 251: 1228.
30. Parish CR, Liew FY. Immune response to chemically modified flagellin: III. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J Exp Med 1972; 135: 298.
31. Lo D, Burkly LC, Flavell RA, Palmiter RD, Brinster RL. Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells. J Exp Med 1989; 170: 87.
32. Marquet RL, Heystek GA. Induction of suppressor cells by donor-specific blood transfusions and heart transplantation in rats. Transplantation 1981; 31: 272.
33. Hall BM, Jelbart ME, Gurley KE, Dorsch SE. Specific unrespon-siveness in rats with prolonged cardiac allograft survival after treatment with cyclosporin: mediation of specific suppression by T helper/inducer cells. J Exp Med 1985; 162: 1683.
34. Romagnani S, Parronchi P, De Carli M, et al. Allergen- and parasiste-specific CD4+ human T cell clones exhibit a Th2-like profile of cytokine production [Přete GF, De Carli M, Mastro-mauro C, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human t cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1992; 88: 346.]. FASEB J (in press).
35. Shizuru JA, Seydel KB, Flavin TF, et al. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pre-transplant anti-CD4 monoclonal antibody therapy. Transplantation 1990; 50: 366.
36. Nagao TD, White DJG, Calne RY. Kinetics of unresponsiveness induced by a short course of cyclosporin A. Transplantation 1982; 29: 196.
37. Sandor M, Gajewski T, Thorson J, Kemp JD, Fitch FW, Lynch RG. CD4+ murine T cell clones that express high levels of immunoglobulin binding belong to the interleukin 4-producing T helper cell type 2 subset. J Exp Med 1990; 171: 2171.
38. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 16: 343.
39. Pereira GMB, Miller JF, Shevach EM. Mechanism of action of cyclosporine A in vivo: T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway. J Immunol 1990; 144: 2109.
40. Lowry RP, Gurley KE, Forbes RDC. Immune mechanisms in organ allograft rejection: I. Delayed-type hypersensitivity and lymphocytotoxicity in heart graft rejection. Transplantation 1983; 36: 391.
41. Hall BM, Pearce NW, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine: III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 1990; 171: 141.
42. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 1979; 150: 580.
43. Ausubel FM, Brent R, Kingston RE, et al. Current protocols in molecular biology. New York: Green, 1991.
44. Yokota T, Arai N, Lee F, Rennick D, Mosmann T, Arai K. Use of a cDNA expression vector for isolation of mouse interleukin 2 cDNA clones: expression of T-cell growth factor activity after transfection of monkey cells. Proc Natl Acad Sci USA 1985; 82: 68.
45. Lee F, Yokata T, Otsuka T, et al. Isolatation and characterization of a mouse interleukin cDNA clone that expresses BSF-1 activities and T cell and mast cell stimulating activities. Proc Natl Acad Sci USA 1986; 83: 2061.
46. Issekutz TB, Stolz JM, Meide PVD. Lymphocyte recruitment in delayed-type hypersensitivity: the role of IFN-gamma. J Immunol 1988; 140: 2989.
47. Schnittman SM, Greenhouse JJ, Psallidopoulos CM, et al. Increased viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990; 113: 438.
48. Demetris AJ, Qian S, Sun H, et al. Early events in liver allograft rejection: delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol 1991; 138: 609.
49. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens: A novel pathway for initiation of rejection. J Exp Med 1990; 171: 307.
50. Street NE, Schumacher JH, Fong AT, et al. Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of Thl and Th2 cells. J Immunol 1990; 144: 1629.
51. Loveland BE, Hogarth PM, Ceredig RH, McKenzie IFC. Cells mediating graft rejection in the mouse: I. Lyt-1 cells mediate skin graft rejection. J Exp Med 1981; 153: 1044.
52. Fisher A, Durandy A, Griscelli C. Role of prostaglandin E2 at the induction of nonspecific T lymphocyte-suppressive activities. J Immunol 1981; 126: 1452.
53. Mills CD. Molecular basis of "suppressor" macrophages: arginine metabolism via the nitric oxide synthetase pathway. J Immunol 1991; 146: 2719.
54. van Twuyver E, Kast WM, Mooijaart RJD, Wilmink JM, Melief CJM, de Waal LP. Allograft tolerance induction in adult mice associated with functional deletion of specific CTL precursors. Transplantation 1989; 48: 844.
55. Cassell DJ, Forman J. Regulation of the cytotoxic T lymphocyte response against Qa-1 alloantigens. J Immunol 1990; 144: 4075.
56. O'Garra A, Stapleton G, Dhar V, et al. Productin of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990; 2: 821.
57. van Twuyver E, Kast WM, Mooijaart RJD, Melief CJM, de Waal LP. Induction of transplantation tolerance by intravenous in jection of allogeneic lymphocytes across an H-2 class II mismatch: different mechanisms operate in tolerization across an H-2 class I vs. H-2 class II disparity. Eur J Immunol 1990; 20: 441.
58. Bordes-Aznar J, Kupiec-Weglinski JW, Duarte AJS, Milford EL, Strom TB, Tilney NL. Function and migration of suppressor lymphocytes from cyclosporine-treated heart graft recipients. Transplantation 1983; 35: 185.
59. Hall BM, Jelbart ME, Dorsch SE. Suppressor T cells in rats with prolonged cardiac allograft survival after treatment with cyclosporin. Transplantation 1984; 37: 595.
60. Hendry WS, Tilney NL, Baldwin WM, et al. Transfer of specific unresponsiveness to organ allografts by thymocytes: specific unresponsiveness by thymocyte transfer. J Exp Med 1979; 149: 1042.
61. Hall BM. Mechanism maintaining enhancement of allografts: I. Demonstration of a specific suppressor cell. J Exp Med 1985; 161: 123.
62. Burkly LC, Lo D, Flavell RA. Tolerance in transgenic mice expressing major histocompatibility molecules extrathymically on pancreatic cells. Science 1990; 248: 1364.
63. Abramson SL, Gallin JI. IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol 1990; 144: 625.
64. Martinez OM, Gibbons RS, Garovoy MR, Aronson FR. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. J Immunol 1990; 144: 2211.
65. Go NF, Castle BE, Barrett R, et al. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990; 172: 1625.
66. Horowitz JB, Kaye J, Conrad PJ, Katz ME, Janeway CA Jr. Autocrine growth inhibition of a cloned line of helper T cells. Proc Natl Acad Sci USA 1986; 83: 1886.
67. Zubiaga AM, Munoz E, Huber BT. Production of IL-lalpha by activated Th type 2 cells: its role as an autocrine growth factor. J Immunol 1991; 146: 3849.
68. Tartakovski B, Finnegan A, Muegge K, et al. IL-1 is an autocrine growth factor for T cell clones. J Immunol 1988; 141: 3863.
69. Jayaraman S, Mensi N, Webb DR, Dorf ME. Involvement of protein kinase C in competence induction of macrophages to generate T suppressor cells. J Immunol 1991; 146: 4085.
70. Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nomoto K. Intrathymic clonal deletion of V T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mis-disparate antigens. J Exp Med 1990; 171: 97.
71. Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Nonoto K. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion. J Immunol 1990; 145: 1303.
72. Rosenberg AS, Mizuochi T, Singer A. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts: assessment of MHC class 1 alloantaigens as in vivo helper determinants. J Exp Med 1989; 143: 2452.
73. Lehmann PV, Schumm G, Moon D, et al. Acute lethal graft-versus-host reaction induced by major histocompatibility complex class II-reactive T helper cell clones. J Exp Med 1990; 171: 1485.
74. Gajewski TF, Schell SR, Fitch FW. Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. J Immunol 1990; 144: 4110.
75. Gajewski TF, Schell SR, Nau G, Fitch FW. Regulation of T-cell activation: differences among T cell subsets. Immunol Rev 1989; 111: 79.
76. Muňoz E, Zubiaga AM, Merrow M, Sauter NP, Huber BT. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med 1990; 172: 95.
77. Muňoz E, Beutner U, Zubiaga A, Huber BT. IL-1 activates two separate signal transduction pathways in T helper type II cells. J Immunol 1990; 144: 964.
78. Mercep M, Weissman AM, Frank SJ, Klausner RD, Ashwell JD. Activation-driven programmed cell death and T cell receptor zeta-n expression. Science 1989; 246: 1162.
79. Mercep M, Bonifacino JS, Garcia-Morales P, Samuelson LE, Klausner RD, Ashwell JD. T cell CD3-zeta-n heterodimer expression and coupling to phosphoinositide hydrolysis. Science 1988; 242: 571.
80. Fraser JD, Irving BA, Crabtree GR, Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991; 251: 313.
81. Koulova L, Clark EA, Shu G, Dupont B. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. J Exp Med 1991; 173: 759.
82. Kenick S, Lowry RP, Forbes RDC, Lisbona R. Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: what is "hepatic tolerance"? Transplant Proc 1987; 19: 478.
83. Williams IR, Unanue ER. Costimulatory requirements of murine Thl clones: the role of accessory cell-derived signals in responses to anti-CD3 antibody. J Immunol 1990; 145: 85.
84. Eynon EE, Parker DC. Do small B cells induce tolerance? Transplant Proc 1991; 23: 729.
85. Flye MW, Yu S. Restoration of lymphocyte proliferation and CTL generation by murine rIL-2 after treatment of allogeneic stimulator cells by ultraviolet B irradiation, heat, or paraformaldehyde. Transplantation 1991; 51: 1066.
86. Boyle WJ, Smeal T, Defize LHK, et al. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 1991; 64: 573.
87. Muegge K, Williams TM, Kant J, et al. Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1. Science 1989; 246: 249.
88. Goebl MG. The peptidyl-prolyl isomerase, FK506-binding protein, is most likely the 12 kd endogenous inhibitor 2 of protein kinase C. Cell 1991; 64: 1051.
89. Lin CS, Boltz RC, Siekierka JJ, Sigal NH. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes. Cell Immunol 1991; 133: 269.
90. Granelli-Piperno A. Lymphokine gene expression in vivo is inhibited by cyclosporin A. J Exp Med 1990; 171: 533.
91. Emmel EA, Verweij CL, Durand DB, Higgins KM, Lacy E, Crabtree GR. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 1989; 246: 1617.
92. Ghiara P, Boraschi D, Nencioni L, Ghezzi P, Tagliabue A. Enhancement of in vivo immune response by tumor necrosis factor. J Immunol 1987; 139: 3676.
93. Zhang Y, Lin J-X, Vilcek J. Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappaB-like sequence. Mol Cell Biol 1990; 10: 3818.
94. Brenner DA, O'Hara M, Angel P, Chojkier M, Kanin M. Pro-longed activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature 1989; 337: 661.
95. Lin J-X, Vileek J. Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. J Biol Chem 1987; 262: 11908.
96. Ray A, Sassone-Corsi P, Sehgal PB. A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation. Mol Cell Biol 1989; 9: 5537.
97. Nguyen DT, Eskandari MK, DeForge LE, et al. Cyclosporin A modulation of tumor necrosis factor gene expression and effects in vitro and in vivo. J Immunol 1990; 144: 3822.
98. Jayaraman S, Martin CA, Dorf ME. Enhancement of in vivo cell-mediated immune responses by three distinct cytokines. J Immunol 1990; 144: 942.
99. Almawi WY, Lipman ML, Stevens AC, Zanker B, Hadro ET, Strom TB. Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6 and IFN-gamma. J Immunol 1991; 146: 3523.
100. Hutchinson IF, Shadur CA, Duarte JSA, Strom TB, Tilney NL. Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics. Transplantation 1981; 32: 210.
101. Furue M, Katz SI, Kawakami Y, Kawakami T. Coordinate expression of src family protooncogenes in T cell activation and its modulation by cyclosporine. J Immunol 1990; 144: 736.
102. Cooke MP, Abraham KM, Forbush KA, Perlmutter RM. Regulation of T cell receptor signalling by a src family protein-tyrosine kinase (p56fyn). Cell 1991; 65: 281.
103. Wu J, Palladino MA, Figari IS, Morris RE. Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporin on mitogen-induced cytokine production and lymphoproliferation. Transplant Proc 1991; 23: 238.
104. Meiser BM, Morris RE. The importance of the spleen for the immunosuppressive action of cyclosporine in transplantation. Transplantation 1991; 51: 690.
105. Wrenshall LE, Matas AJ, Canafax DM, et al. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone. Transplantation 1990; 50: 233.
106. Opelz G for the Collaborative Transplantation Study. The role of HLA matching and blood transfusion in the cyclosporin era. Transplant Proc 1989; 21: 609.
107. Qin S, Wise M, Cobbold SP, et al. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 1990; 20: 2737.
108. Cobbold SP, Martin G, Waldmann H. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol 1990; 20: 2747.
109. Veillette A, Bookman MA, Horák EM, Samelson LE, Bolen JB. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56'ck. Nature 1989; 338: 257.
110. Veillette A, Zuniga-Pflucker JC, Bolen JB, Kruisbeek AM. Engagement of CD4 and CD8 expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways. J Exp Med 1989; 170: 1671.
111. Abraham N, Miceli MC, Parnes JR, Veillette A. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature 1991; 350: 62.
112. Cowdery JS, Tolaymat N, Weber SP. The effect of partial in vivo depletion of CD4 T cells by monoclonal antibodies: evidence that incomplete depletion increases IgG production and augments in vitro thymic-dependent antibody responses. Transplantation 1991; 51: 1072.
113. Koretzky GA, Picus J, Schultz T, Weiss A. Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc Natl Acad Sci USA 1991; 88: 2037.
114. Madsen JC, Superina RA, Wood KJ, Morris PJ. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988; 332: 161.
115. Coutinho A, Bandeira A. Tolerize one, tolerize them all: tolerance is self-assertion. Immunol Today 1989; 10: 364.
116. Ernst DN, Hobbs MV, Torbett BE, et al. Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice. J Immunol 1990; 145: 1295.
117. Luqman M, Johnson P, Trowbridge I, Bottomly K. Differential expression of the alternatively spliced exons of murine CD45 in Thl and Th2 cell clones. Eur J Immunol 1991; 21: 17.
118. Hayakawa K, Hardy RR. Murine CD4+ T cell subsets defined. J Exp Med 1988; 168: 1825.
119. Hayakawa K, Hardy RR. Phenotypic and functional alteration of CD4+ T cells after antigen stimulation. J Exp Med 1989; 169: 2245.